Shruti Sridhar1, Nadira Maleq2, Elise Guillermet2, Anais Colombini2, Bradford D Gessner3. 1. Agence de Médecine Preventive, 164 Rue de Vaugirard, Paris 75015, France. Electronic address: shrutilion@gmail.com. 2. Agence de Médecine Preventive, 164 Rue de Vaugirard, Paris 75015, France. 3. Agence de Médecine Preventive, 164 Rue de Vaugirard, Paris 75015, France. Electronic address: bgessner@aamp.org.
Abstract
BACKGROUND: Missed opportunities for immunization (MOIs) may contribute to low coverage in diverse settings, including developing countries. METHODS: We conducted a systematic literature review on MOIs among children and women of childbearing age from 1991 to the present in low- and middle-income countries. We searched multiple databases and the references of retrieved articles. Meta-analysis provided a pooled prevalence estimate and both univariate and multivariate meta-regression analysis was done to explore heterogeneity of results across studies. RESULTS: We found 61 data points from 45 studies involving 41,310 participants. Of the 45 studies, 41 involved children and 10 involved women. The pooled MOI prevalence was 32.2% (95% CI: 26.8-37.7) among children - with no change during the study period - and 46.9% (95% CI: 29.7-64.0%) among women of child-bearing age. The prevalence varied by region and study methodology but these two variables together accounted for only 12% of study heterogeneity. Among 352 identified reasons for MOIs, the most common categories were health care practices, false contraindications, logistic issues related to vaccines, and organizational limitations, which did not vary by time or geographic region. CONCLUSIONS: MOI prevalence was high in low- and middle-income settings but the large number of identified reasons precludes standardized solutions.
BACKGROUND: Missed opportunities for immunization (MOIs) may contribute to low coverage in diverse settings, including developing countries. METHODS: We conducted a systematic literature review on MOIs among children and women of childbearing age from 1991 to the present in low- and middle-income countries. We searched multiple databases and the references of retrieved articles. Meta-analysis provided a pooled prevalence estimate and both univariate and multivariate meta-regression analysis was done to explore heterogeneity of results across studies. RESULTS: We found 61 data points from 45 studies involving 41,310 participants. Of the 45 studies, 41 involved children and 10 involved women. The pooled MOI prevalence was 32.2% (95% CI: 26.8-37.7) among children - with no change during the study period - and 46.9% (95% CI: 29.7-64.0%) among women of child-bearing age. The prevalence varied by region and study methodology but these two variables together accounted for only 12% of study heterogeneity. Among 352 identified reasons for MOIs, the most common categories were health care practices, false contraindications, logistic issues related to vaccines, and organizational limitations, which did not vary by time or geographic region. CONCLUSIONS: MOI prevalence was high in low- and middle-income settings but the large number of identified reasons precludes standardized solutions.
Authors: Abdu A Adamu; Olalekan A Uthman; Elvis O Wambiya; Muktar A Gadanya; Charles S Wiysonge Journal: Hum Vaccin Immunother Date: 2019-04-22 Impact factor: 3.452
Authors: Lori K Handy; Stefania Maroudi; Maura Powell; Bakanuki Nfila; Charlotte Moser; Ingrid Japa; Ndibo Monyatsi; Elena Tzortzi; Ismini Kouzeli; Anthony Luberti; Maria Theodoridou; Paul Offit; Andrew Steenhoff; Judy A Shea; Kristen A Feemster Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240
Authors: Aaron S Wallace; Kong Krey; John Hustedt; Eleanor Burnett; Narin Choun; Danni Daniels; Margaret L Watkins; Sann Chan Soeung; Richard Duncan Journal: Vaccine Date: 2018-06-19 Impact factor: 3.641